methotrexate improves long-term SURVIVAL in rheumatoid arthritis patients

May 2002

Exciting new research suggests that methotrexate improves long-term SURVIVAL in rheumatoid arthritis patients.

It's well known that methotrexate slows the progression of RA... but it seems to improve survival by reducing cardiovascular deaths.

RA patients have an increased risk of heart disease. It's thought that some of the same inflammation that causes joint damage might also lead to atherosclerosis and heart disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote